KRAS and neoplasm: The degree of tumor differentiation, lymph node metastasis, TNM staging, CA125 > 35.00 U/ml, KRAS mutations, and CTC counts ≥2 per 3.2 ml were significantly associated with DFS (P < 0.05, Table 6).